Randomised Trial of Rituximab in C4d+ Chronic Renal Transplant Rejection

Update Il y a 4 ans
Reference: EUCTR2006-002330-38

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine whether anti-CD20 therapy can stabilise or improve renal function and/or proteinuria in patients with C4d+, chronic (humoral) rejection in whom standard therapeutic approaches have failed.


Inclusion criteria

  • Renal Transplant Rejection - chronic

Links